SR-8993

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSR-8993
Drug Alias Namenociceptin/orphanin FQ receptor agonist (University of Miami/The Scripps Research Institute/Emory University)SR-8993
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNociceptin receptor agonists
TargetsNociceptin receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticAlcoholismSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of MiamiEmory UniversityThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsStress Disorders, Post-TraumaticAlcoholismSubstance-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A